Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 17UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 11Esophageal Neoplasms 2Locally Advanced Pancreatic Cancer 1HER2-positive 1Gastrointestinal Neoplasms 1Breast Cancer Recurrent 1Advanced Pancreatic Cancer 1

Interventions

Paclitaxel 8nedaplatin 3TP protocol 3nimotuzumab 2S 1 (combination) 2Radiation 2Esophagectomy 2Cisplatin 2pegylated granulocyte colony-stimulating factor 1Radiotherapy, Adjuvant 1Platinum 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × Esophageal Neoplasms × S 1 (combination) × Clear all
NCT02979691 2020-07-21

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

ChineseAMS

Phase 2/3 Completed
350 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02319187 2015-08-03

Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

ChineseAMS

Phase 3 Unknown
240 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡